title: Suprahepatic venacavaplasty (cavaplasty) with retrohepatic cava extension in liver transplantation: experience with first 115 cases.
abstract: BACKGROUND
  We first introduced the orthotopic liver transplantation utilizing cavaplasty technique in 1994. This paper describes the surgical technique and assesses the outcome of the cavaplasty OLT.
  
  
  METHODS
  The cavaplasty procedure was used in 115 consecutive orthotopic liver transplantations, including six left lateral and two right lobe transplantations, between November 1994 and September 2000. Fifty-three (66.3%) transplantations required femoro-axillary veno-venous bypass in the initial 4 years, whereas only eight (22.9%) needed VB in the subsequent 2 years. Conversion to piggyback or standard technique was not necessary in any patient.
  
  
  RESULTS
  Median results are as follows: operative time 4.5 hr, warm ischemia time 25 min, and blood transfused (packed red blood cells) 6 units. These findings did not differ between first transplantation and retransplantation. There were no perioperative deaths related to the cavaplasty technique. No hepatic venous outflow obstruction was observed, including living-related OLTs. No patient required postoperative hemodialysis for acute renal failure. The median intensive care and hospital stays were 2 days and 10 days, respectively.
  
  
  CONCLUSIONS
  The cavaplasty technique requires no retrocaval, hepatic vein, or short hepatic vein dissection, and the inferior vena cava can be preserved, which provides advantages for hepatectomy and easy hemostasis, especially during retransplantation. The wide-open triangular caval anastomosis is easy to perform, allowing short implantation time and size matching and avoiding outflow obstruction. The short implantation time reduces the need for veno-venous bypass. Our experience indicates that the cavaplasty technique can be applied to all patients and is justified by minimal technical complications.
authors.affiliation: Department of Surgery, University of Iowa, 200 Hawkins Dr., Iowa City, IA 52242, USA. you-wu@uiowa.edu
authors.forename: Y M
authors.initials: YM
authors.lastname: Wu
authors.forename: M
authors.initials: M
authors.lastname: Voigt
authors.forename: S
authors.initials: S
authors.lastname: Rayhill
authors.forename: D
authors.initials: D
authors.lastname: Katz
authors.forename: R Y
authors.initials: RY
authors.lastname: Chenhsu
authors.forename: W
authors.initials: W
authors.lastname: Schmidt
authors.forename: R
authors.initials: R
authors.lastname: Miller
authors.forename: F
authors.initials: F
authors.lastname: Mitros
authors.forename: D
authors.initials: D
authors.lastname: Labrecque
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006498:Hepatectomy; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects / Q000379:methods*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D014684:Venae Cavae / Q000601:surgery*